820.50
+2.50%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Remus Pharmaceuticals
Its shares trade on NSE under the ticker REMUS.NS. It has been listed since 29 May 2023. In the fiscal year to 31 March 2025, it reported revenue of ₹6.20bn and net income of ₹290.7m. At that date it held total assets of ₹4.33bn and shareholders' equity of ₹2.56bn.
Remus Pharmaceuticals Ltd. operates as a pharmaceutical company. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2023-05-29. The company also deals in active pharmaceutical ingredients (API). The firm also provides technical consulting services to various distributors for the preparation of reports on the dossiers of the products. The company deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension, and tablet. The Company’s business verticals include the sale of finished formulations, the sale of APIs, and technical consulting. Its product portfolio comprises a range of therapeutic drugs, namely ACE inhibitors, analgesics, anti-erectile dysfunction, anti-fibrinolytics, anti-histamines, beta blockers, carcinoid tumors, chronic obstructive pulmonary disease, and contrast reagents, among others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 29 May 2023
- Employees
- 38
- Website
- remuspharma.com ↗
Leadership
Pay as last reported
- Mr. Swapnil ShahExecutive Chairman of the Board, since 2023₹3.5m
- Ms. Anjali ShahChief Financial Officer
- Ms. Deval PatelCompliance Officer, Company Secretary
- Mr. Arpit ShahManaging Director, Executive Director, since 2023₹8.7m
- Mrs. Anar ShahWhole Time Director, since 2020₹3.5m
- Ms. Roma ShahWhole Time Director, since 2023₹9.7m
- Mr. Vishrut PathakNon-Executive Independent Director
- Mr. Balwant PurohitNon-Executive Independent Director
- Ms. Sanjana ShahNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Remus Pharmaceuticals Ltd. employs 38 full-time employees in Ahmedabad, Gujarat.
- The company offers technical consulting services for product dossier reports to distributors.
- Remus Pharmaceuticals provides a wide range of drug forms including capsules, injections, and ointments.
Weaknesses
- The company has a small workforce of 38 employees in the Health Care sector.
- Remus Pharmaceuticals has only one business vertical for API sales.
- The company's product portfolio includes limited therapeutic categories like ACE inhibitors.
Opportunities
- Remus Pharmaceuticals can expand API sales to international markets like the United States.
- The company can leverage its technical consulting services to enter new markets.
- Remus Pharmaceuticals can grow its product portfolio with more therapeutic categories.
Threats
- Remus Pharmaceuticals faces competition from established API suppliers in India.
- The company's small size may limit its ability to compete with larger pharmaceutical firms.
- The Health Care sector in India has high regulatory requirements for new products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.